跳至主要内容
临床试验/KCT0005833
KCT0005833招募中未知

Effect of Udenafil Administration for Blood Flow Increase in the Prefrontal Cortex

Jeonbuk National University Hospital0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
55(Year) 至 65(Year)(—)
性别
Male

入选标准

  • Adult males aged 55 to 65 years old
  • -After hearing and understanding the detailed explanation of this study, the subject voluntarily decides to participate in the study and gives written consent
  • -When the MMSE score is taken into account of age, gender, and education level, it is at a normal level of mean-1SD or higher.
  • -Those who are willing to cooperate with this study and complete all phases of clinical trials, and who are practically viable

排除标准

  • 1. If you have a history of stroke, myocardial infarction, or CABG surgery within the past 6 months
  • 2. Has a history of cardiac failure, unstable angina, or life-threatening arrhythmia within the last 6 months
  • 3. If you have uncontrolled diabetes
  • 4. If you have proliferative diabetic retinopathy
  • 5. Spinal cord injury, radical prostatectomy and radical pelvic surgery
  • 6. If you have hypotension of less than 90/50mmHg or uncontrolled hypertension of more than 170/100mmHg
  • 7. If there is an abnormality in liver function or kidney function
  • 8. If you have retinitis pigmentosa
  • 9. Severe active peptic ulceration within the past year
  • 10. If you have a blood disorder (sickle cellosis, multiple myeloma, leukemia) or bleeding disorder that may predispose to persistent erection
  • 11. In case the researcher determines that it is unsuitable for participation in the test, such as mental disorder or continuous abuse of drugs
  • 12. When taking Nitrates/Nitric oxide(NO) donor (ex. nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrate/nitrite, Sodium nitroprusside)
  • 13. If you are being treated with cancer chemotherapy
  • 14. If you are taking anticoagulants
  • 15. Taking drugs or foods that affect the metabolism of CYP3A4 in the liver
  • 16. If you are taking Androgens (ex. testosterone) or anti-androgens
  • 17. Use of other PDE-5 inhibitors (Viagra®, Levitra® and Cialis®) or other erectile dysfunction treatments for the treatment of erectile dysfunction within 2 weeks prior to trial
  • 18. History of hypersensitivity to other PDE-5 inhibitors (Viagra®, Levitra® and Cialis®)

研究者

相似试验

进行中(未招募)
不适用
Treatment with Sildenafil in patients with heart failureTo investigate acute effects of sildenafil on cardiac hemodynamics, right ventricle performance and cGMP concentrations in heart failure patients with preserved ejection fraction and patients after heart transplantationMedDRA version: 16.0Level: LLTClassification code 10037406Term: Pulmonary hypertension secondarySystem Organ Class: 100000004855
EUCTR2013-001659-10-BEZLeuven
已完成
不适用
Effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms secondary to benign prostate hyperplasiabenign prostate hyperplasia
JPRN-UMIN000016034Department of Urology, Kyorin University School of Medicine50
进行中(未招募)
1 期
Pharmacological intervention of blood flow disturbances in diabetic retinal disease - Retinal blood flow and diabetesDiabetic retinal diseaseMedDRA version: 9.1Level: LLTClassification code 10012661Term: Diabetic eye disease
EUCTR2007-001697-84-DKDepartment of Ophthalmology, Aarhus University Hospital80
已完成
不适用
The haemodynamic effect of sildenafil in mechanically ventilated patients with secondary pulmonary hypertension and ensuing right ventricular failure necessitating the administration of dobutamineSecondary pulmonary hypertension, right ventricular failureCirculatory SystemPulmonary hypertension
ISRCTN35752874General State Hospital of Athens (Greece)12
已完成
不适用
Study on the effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms due to benign prostatic hyperplasiaPatients with lower urinary tract symptoms due to benign prostatic hyperplasia
JPRN-UMIN000020658Hidehiro Kakizaki22